by Company Biotechnology BiomX

BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Bacteriophage product pipeline:

  • Acne (BX001)
  • IBD/PSC (BX003)
  • Cystic Fibrosis (BX004)
  • Atopic Dermatitis (BX005)
  • Colorectal Cancer

This website uses cookies. Accept Read More